Kidney Cancer Book #1 Best Seller Status on Amazon.com

Photo of author

STOCKTON, CALIFORNIA/June 13, 2013 / Newswire/ — Viratech Corp. (OTC:VIRA) announced today that Cancer.im’s  7th   book of  235 books slated to be  released on Amazon’s Kindle platform, focusing on Cancer, has achieved number 1 best-seller status for Oncology.

The book, Find & Stop Kidney Cancer by Dr. Kevin Buckman and Cancer Patient Advocate Chris Ryan, has achieved number 1 best-seller status for Oncology. The first book, Find and Stop Breast Cancer, became a best seller earlier this year after only three days. The book Find & Stop Kidney Cancer can be bought here: Kidney Cancer Find & Stop 

Dr Buckman, states, All too often Kidney cancer is found at late stages, since it can be hidden with little or no symptoms.  This book is meant to raise awareness about kidney cancer, and also about cancer in general, and how important that early detection and treatment is.  We dedicated this to a local friend who has kidney cancer spread throughout his body.  He is only 22 years old.?

 The different types of kidney cancer develop in different ways, meaning that the diseases have different outlooks (or prognosis), and need to be staged and treated in different ways. The most common signs and symptoms of kidney cancer are a lump in the abdomen and/or blood in the urine (or hematuria). Other symptoms may include tiredness, loss of appetite, weight loss, a high temperature and heavy sweating, and persistent pain in the abdomen.  However, many of these symptoms can be caused by other conditions, and there may also be no signs or symptoms in a person with kidney cancer, especially in the early stages of the disease.

Cancer is a diverse class of diseases which differ widely in their causes and biology. Any organism can acquire cancer. Nearly all known cancers arise gradually, as errors build up in the cancer cell, and its progeny and cancer cells can be found in our bodies since childhood and increase with age and exposure to carcinogens.

 According to the book, Cancer.im (www.cancer.im) is working to find new screening tests for cancer and new modes of therapy. The site, which launched on February 15, 2013, includes a user friendly Mission Adaptive Plan (a MAP) that can be tailored for each user, and 15 modules for dealing with the disease, which are based on the Robert Ryan Cancer Protocol. Based on more than 19 medical studies on quality of life and associated longevity, following the Robert Ryan Cancer Protocol decreases the morbidity of cancer by increasing the quality of life by the use of these 15 steps which allows a cancer patient to be proactive.  There is no charge for this service.? An explanatory video of the power of a Cancer Support Social Network can be seen here: http://www.youtube.com/watch?v=dz1tHRb3wvU

 About Cancer.im

 Through its experience-based search engine and technology, Cancer.im’s goal is to become the primary resource on the web for people affected by cancer, for the purpose of making a difference in their own lives and the lives of others.  Cancer.im?s mission is to empower every cancer patient with the ability to research their disease and to find, organize, and manage their own cancer support network at no charge to them. The goal of these support networks is to assist the patient in conserving needed energy by reducing the burden associated with their own daily trials and tribulations. Cancer.im will strive to convert this saved energy into a higher level of patient activity and a stronger determination to fight their disease.

 In addition Cancer.im is seeking new cancer researchers who wish to leverage its intellectual property and social network platform for the purpose of creating new distribution and engagement channels.

 About Viratech Corp.

 Viratech Corp. has created the first open source biotech research social network platform. The purpose of the platform is to make it possible for individuals or smaller companies to compete with larger companies in the race to patent new medicines or technology. This has been made possible by leveraging social collaboration in a way that allows new biotech ventures the ability to protect their intellectual property, then simultaneously allowing those same ventures the ability to promote and crowdsource their development.

Contact: Kevin Buckman MD

Viratech, Corp.

http://viratech.org

Email Contact: info@viratech.org

209-477-3030